Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Paolini JF"" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł:
Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire: results from a randomised placebo-controlled clinical trial.
Autorzy:
Paolini JF
Mitchel YB
Reyes R
Thompson-Bell S
Yu Q
Lai E
Watson DJ
Norquist JM
Sisk CM
Bays HE
Paolini, J F
Mitchel, Y B
Reyes, R
Thompson-Bell, S
Yu, Q
Lai, E
Watson, D J
Norquist, J M
Sisk, C McCrary
Bays, H E
Pokaż więcej
Źródło:
International Journal of Clinical Practice; Jun2008, Vol. 62 Issue 6, p896-904, 9p
Czasopismo naukowe
Tytuł:
Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta.
Autorzy:
Hashimoto T; Miami Itch Center, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.; Department of Dermatology, National Defense Medical College, Tokorozawa, Japan.
Nattkemper LA; Miami Itch Center, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Kim HS; Miami Itch Center, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Kursewicz CD; Miami Itch Center, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Fowler E; Miami Itch Center, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Shah SM; Miami Itch Center, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Nanda S; Miami Itch Center, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Fayne RA; Miami Itch Center, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Paolini JF; Kiniksa Pharmaceuticals Corp, Lexington, Massachusetts, USA.
Romanelli P; Miami Itch Center, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Yosipovitch G; Miami Itch Center, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Pokaż więcej
Źródło:
Experimental dermatology [Exp Dermatol] 2021 Jun; Vol. 30 (6), pp. 804-810. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Interleukins/*metabolism
Oncostatin M/*metabolism
Oncostatin M Receptor beta Subunit/*metabolism
Prurigo/*metabolism
Pruritus/*metabolism
Receptors, Interleukin/*metabolism
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł:
Oncostatin M Induction of Monocyte Chemoattractant Protein 1 is Inhibited by Anti-oncostatin M Receptor Beta Monoclonal Antibody KPL-716.
Autorzy:
Richards CD; Department of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, L8S4L8 Hamilton, Canada. E-mail: .
Gandhi R
Botelho F
Ho L
Paolini JF
Pokaż więcej
Źródło:
Acta dermato-venereologica [Acta Derm Venereol] 2020 Jul 02; Vol. 100 (14), pp. adv00197. Date of Electronic Publication: 2020 Jul 02.
Typ publikacji:
Journal Article
MeSH Terms:
Chemokine CCL2*/genetics
Chemokine CCL2*/metabolism
Gene Expression Regulation*
Antibodies, Monoclonal/pharmacology ; Cells, Cultured ; Humans ; Interleukin-13 ; Oncostatin M/metabolism
Czasopismo naukowe
Tytuł:
HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation.
Autorzy:
Tardy C; Cerenis Therapeutics SA, Labege, France.
Goffinet M; Cerenis Therapeutics SA, Labege, France.
Boubekeur N; Cerenis Therapeutics SA, Labege, France.
Cholez G; Cerenis Therapeutics SA, Labege, France.
Ackermann R; Cerenis Therapeutics Inc., Ann Arbor, Michigan, United States of America.
Sy G; Cerenis Therapeutics Inc., Ann Arbor, Michigan, United States of America.
Keyserling C; Cerenis Therapeutics SA, Labege, France.
Lalwani N; Cerenis Therapeutics Inc., Ann Arbor, Michigan, United States of America.
Paolini JF; Cerenis Therapeutics SA, Labege, France.
Dasseux JL; Cerenis Therapeutics SA, Labege, France.
Barbaras R; Cerenis Therapeutics SA, Labege, France.
Baron R; Cerenis Therapeutics SA, Labege, France.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Sep 03; Vol. 10 (9), pp. e0137584. Date of Electronic Publication: 2015 Sep 03 (Print Publication: 2015).
Typ publikacji:
Journal Article
MeSH Terms:
ATP Binding Cassette Transporter 1/*metabolism
Apolipoprotein A-I/*pharmacology
Down-Regulation/*drug effects
Lipoproteins, HDL/*pharmacology
Phospholipids/*pharmacology
Plaque, Atherosclerotic/*prevention & control
Recombinant Proteins/*pharmacology
ATP Binding Cassette Transporter 1/genetics ; Animals ; Apolipoproteins E/genetics ; Dose-Response Relationship, Drug ; Mice ; Plaque, Atherosclerotic/genetics ; Plaque, Atherosclerotic/metabolism
Czasopismo naukowe
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies